Recent advancements in liquid biopsies have demonstrated the potential of cfDNA as a universal, minimally invasive sample type in cancer prognosis, diagnosis, and prenatal testing 1. In parallel, the ...

More than 30 abstracts presented at the 60th American Society of Hematology (ASH) Annual Meeting & Exposition in San Diego, December 1-4, featured research highlighting the ability of Bio-Rad's ...

Circulating miRNA Signature Predicts Response to Preoperative Chemoradiotherapy in Locally Advanced Rectal Cancer We developed a ddPCR assay to sensitively detect tumor-derived hypermethylated RASSF1A ...

Study findings indicate that droplet digital polymerase chain reaction (ddPCR) may be more accurate than real-time quantitative PCR in measuring minimal residual disease (MRD) among pediatric patients ...

A recent review took a look at the promise of measuring circulating tumor DNA (ctDNA) with digital-droplet PCR (ddPCR) in pancreatic ductal adenocarcinoma (PDAC) as the landscape of this cancer ...

Cell-based therapies and other advanced biologics have transformed the pharmaceutical landscape, but they’ve also introduced new challenges for quality control (QC). One persistent threat to the ...

Bio-Rad (CA, USA), a clinical diagnostics products company, has launched a new ddPCR kit designed to assess AAV vector quality for gene therapy development. Vericheck ddPCR Empty-Full Capsid Kit can ...

Droplet digital polymerase chain reaction (ddPCR) technology is emerging as an efficient, accurate, and precise way to measure transgene copy numbers. With it, scientists may screen for clonal ...

Let us help you with your inquiries, brochures and pricing requirements Request A Quote Download PDF Copy Download Brochure Accurate viral vector characterization in ...

Bio-Rad Laboratories Inc. (NYSE: BIO and BIOb) today released the One-Step RT-ddPCR Advanced Kit for Probes which combines reverse transcription and Droplet Digital PCR (RT-ddPCR) for absolute RNA ...